To accurately grasp the development trend of the pharmaceutical industry and scientifically plan the layout of the industrial chain, the Zibo Municipal Chamber of Commerce for Pharmaceuticals organized a special visit on the city's pharmaceutical industry. On the morning of August 13, the delegation visited SMA PHARMATECH for an on-site inspection. Zheng Jiaqing, President of the Municipal Chamber of Commerce for Pharmaceuticals and Chairman of Qidu Pharmaceutical; Miao Dezu, Vice President of the Chamber of Commerce and Chairman of Ruiyang Pharmaceutical; Zhao Yeqing, Chairman of Jincheng Pharmaceutical; Bao Lamei, President of Heda Group; and Huo Xiaoyu, Secretary-General of the Chamber of Commerce, and other leaders joined the visit.

Yin Wenping, Chair of the Supervisory Board of the Municipal Chamber of Commerce for Pharmaceuticals, Chairman and General Manager of SMA PHARMATECH, extended a warm welcome to the delegation and accompanied the visit. He gave a detailed introduction to the company's practical achievements in technological innovation, intelligent manufacturing and industrial development. He led the delegation to visit the innovative process laboratory, production workshop and talent apartment, focusing on demonstrating the company's technological breakthroughs in the field of pharmaceutical equipment, the operational effectiveness of the continuous manufacturing experimental platform and the mechanism for cultivating innovative talents.

The delegation spoke highly of SMA's innovative R&D capabilities, intelligent production level and modern enterprise management model in the field of pharmaceutical equipment. President Zheng Jiaqing said that the current pharmaceutical industry is in a critical period of transformation and upgrading. Taking this visit as an opportunity, the chamber of commerce will further build a platform for enterprise exchanges and cooperation, promote in-depth linkage among member units in terms of technology sharing, resource complementarity, and talent co-cultivation, work together to solve common problems in industrial development, and build consensus and pool strength for the high-quality development of Zibo's pharmaceutical industry.